Catalyst Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Catalyst Pharmaceuticals Inc in one report.
- Save hours of research time and resources with
our up-to-date Catalyst Pharmaceuticals Inc Strategy Report
- Understand Catalyst Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Catalyst Pharmaceuticals Inc (Catalyst) is a development-stage specialty pharmaceutical company that focuses on the development and commercialization of prescription drugs targeting rare neurological and neuromuscular diseases. The company’s lead product, Firdapse; and improved business performance are its major strengths, while customer dependency remains causes for concern. Catalyst could find opportunities from its strategic acquisitions, growing healthcare expenditure in the US, and unmet medical need for LAMS. However, it could face challenges from increased drug scrutiny, intense competition and third party dependence.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer